New Trisubstituted 1,2,4-Triazole Derivatives as Potent Ghrelin Receptor Antagonists. 3. Synthesis and Pharmacological in Vitro and in Vivo Evaluations
Authors:
- 15 January 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 51 (3) , 689-693
Abstract
Ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure were synthesized and evaluated for their in vitro binding and biological activity. In this study, we explored the replacement of the α-aminoisobutyryl moiety by aromatic or heteroaromatic groups. Compounds 5 and 34 acted as potent in vivo antagonists of hexarelin-stimulated food intake. These two compounds did not stimulate growth hormone secretion in rodents and did not antagonize growth hormone secretion induced by hexarelin.Keywords
This publication has 17 references indexed in Scilit:
- Quinazolinone Derivatives as Orally Available Ghrelin Receptor Antagonists for the Treatment of Diabetes and ObesityJournal of Medicinal Chemistry, 2007
- Synthesis and Pharmacological in Vitro and in Vivo Evaluations of Novel Triazole Derivatives as Ligands of the Ghrelin Receptor. 1Journal of Medicinal Chemistry, 2007
- Discovery and Pharmacological Evaluation of Growth Hormone Secretagogue Receptor AntagonistsJournal of Medicinal Chemistry, 2006
- 2,4-Diaminopyrimidine Derivatives as Potent Growth Hormone Secretagogue Receptor AntagonistsJournal of Medicinal Chemistry, 2006
- Ghrelin: Structure and FunctionPhysiological Reviews, 2005
- Biological, Physiological, Pathophysiological, and Pharmacological Aspects of GhrelinEndocrine Reviews, 2004
- Antagonism of ghrelin receptor reduces food intake and body weight gain in miceGut, 2003
- A role for ghrelin in the central regulation of feedingNature, 2001
- Ghrelin is a growth-hormone-releasing acylated peptide from stomachNature, 1999
- A Receptor in Pituitary and Hypothalamus That Functions in Growth Hormone ReleaseScience, 1996